NAD+ and Sirtuin Research: Pathways and Reference Compounds
A research-grade review of NAD+ research, NAD+ sirtuins, precursors, and emerging modulators including the SLU-PP-332 ERR agonist and the 5-Amino-1-MQ NNMT inhibitor, for aging-biomarker studies.
